Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation

Roman Kulikov1, Markus Winter, Christine Blattner

  • 1Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe, 76021 Karlsruhe, Germany.

Insights

The Mdm2 protein regulates tumor suppressor p53. Mdm2

Area of Science:

  • Molecular Biology
  • Oncology
  • Protein Interactions

Background:

  • The Mdm2 protein is a key regulator of the tumor suppressor protein p53.
  • Understanding the interaction between Mdm2 and p53 is crucial for cancer research.

Purpose of the Study:

  • To investigate the binding sites and synergistic interactions between Mdm2 and p53.
  • To determine the role of Mdm2 phosphorylation in p53 binding.

Main Methods:

  • Protein-protein interaction studies.
  • Site-directed mutagenesis.
  • Analysis of p53 mutants.

Main Results:

  • p53 binds to both N-terminal and central domains of Mdm2.
  • The central binding site spans amino acids 235-300.
  • Phosphorylation of Mdm2's central domain enhances p53 binding.
  • N-terminal and central domains of Mdm2 synergistically bind p53.
  • p53 mutants affecting oligomerization show reduced binding enhancement.

Conclusions:

  • Mdm2 and p53 interaction is complex, involving multiple binding domains.
  • Phosphorylation of Mdm2 is a critical regulatory mechanism for p53 binding.
  • Synergistic action of Mdm2 domains is essential for efficient p53 regulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...